drugset / Trial / NCT03582215

Assessment of the Human Systemic Absorption of Sunscreen Ingredients

NCT03582215

RandomizedParallel-groupOpen-labelOther

Summary

This study is designed to assess the systemic exposure and pharmacokinetics of sunscreen active ingredients (avobenzone, oxybenzone, ecamsule, octocrylene homosalate, octisalate and octinoxate) when sunscreen product is applied under maximal use conditions. Part 1 is an open-label, randomized, 4-arm study in 24 healthy adult subjects with the primary objective to explore whether the active components (avobenzone, oxybenzone, ecamsule and octocrylene) of 4 sunscreen products (1 sunscreen product in each arm) are absorbed into the systemic circulation when a sunscreen product is applied under maximal use conditions. One sunscreen product with the highest avobenzone exposure will be selected for the second part of the study. If there is no quantifiable exposure of avobenzone for any of the sunscreen products, the formulation with the highest oxybenzone exposure will be selected for Part 2. In addition, 3 new sunscreen products are included in Part 2. Part 2 is an open label, 4-arm study in 48 healthy adult subjects with the primary objective to assess the pharmacokinetics of the active components in the selected product from Part 1 and 3 additional products with a combination of active ingredients (avobenzone, oxybenzone, octocrylene, ecamsule homosalate, octisalate and octinoxate as applicable/contained in the different products).

Timeline

Start
2018-07-18
Primary completion
2019-02-18
Completion
2019-02-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Avobenzone Small molecule 2 unknown Topical
Subject Homosalate Small molecule 2 unknown Topical
Subject Mexoryl SX / XL Unknown 2 unknown Topical
Subject Octinoxate Small molecule 2 unknown Topical
Subject Octisalate Small molecule 2 unknown Topical
Subject Octocrylene Small molecule 2 unknown Topical
Subject Oxybenzone Small molecule 2 unknown Topical